SCHEMBL19969987

SCHEMBL19969987

CCCOCc1nn(CC(F)F)c2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR3A P46098 5/20 0.39
▸ SLC16A3 O15427 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ MITF O75030 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ELANE P08246 2/20 0.33
▸ SCN8A Q9UQD0 1/20 0.33
▸ HDAC3 O15379 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC10 Q969S8 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ NCOR2 Q9Y618 1/20 0.32
▸ AKR1B1 P15121 1/20 0.32
▸ CNR1 P21554 2/20 0.32
▸ CNR2 P34972 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19969988 0.84 SLC16A3 (0.40) HTR3ASLC16A3KDM4ENPC1BRD4
SCHEMBL19970005 0.81 L3MBTL1 (0.43) HTR3AKDM4ENPC1BRD4MITF
SCHEMBL13168765 0.73 ALOX15 (0.41) SLC16A3KDM4ENPC1BRD4MITF
SCHEMBL31066609 0.72 HTR7 (0.36) HTR3ASLC16A3SCN8AAKR1B1CNR1
SCHEMBL19969853 0.71 HTR3A (0.42) HTR3AKDM4EL3MBTL1HDAC1HDAC6
SCHEMBL22849913 0.69 SLC16A3 (0.62) SLC16A3KDM4ENPC1SCN8AHDAC3
SCHEMBL17326655 0.67 HSD17B10 (0.59) HTR3AKDM4EL3MBTL1ALDH1A1LMNA
SCHEMBL22849936 0.67 SLC16A3 (0.64) SLC16A3KDM4ENPC1SCN8AHDAC3
SCHEMBL17176491 0.67 HTR3A (0.59) HTR3AKDM4EELANECNR1CNR2
SCHEMBL1603187 0.67 CYP1A2 (0.61) SLC16A3KDM4ENPC1SCN8AHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180072758-A1 5HT3 RECEPTOR ANTAGONISTS TAKEDA CALIFORNIA, INC. 2018-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180072758-A1 5HT3 RECEPTOR ANTAGONISTS HTR3A, HTR3B, HTR5A HTR3A 1/4885SLC16A3 534/4885KDM4E 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback